Turbulence and deceleration capacity of the heart rate in patients with coronary artery disease and implanted cardioverter defibrillator

Turbulence and deceleration capacity of the heart rate in patients with coronary artery disease and implanted cardioverter defibrillator

Aim. To study the possibility of using of heart rate turbulence (HRT) and deceleration capacity (DC) in the risk stratification of fatal events in patients with coronary artery disease (CAD) and implanted cardioverter defibrillator (ICD).Material and methods. The study included 45 patients with sinu...

Full description

Bibliographic Details
Main Authors:	N. V. Melnik, D. A. Tsaregorodtsev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2019-08-01
Series:	Российский кардиологический журнал
Subjects:	sudden cardiac death cardiac rhythm turbulence deceleration capacity of the heart rate coronary artery disease cardioverter defibrillator
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/3354

Similar Items

Implantable cardioverter defibrillators: Uses, abuses, gains and complications
by: Weiwei Li, et al.
Published: (2017-04-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Real world utilization and impact of the wearable cardioverter-defibrillator in a community setting
by: Aditi Naniwadekar, et al.
Published: (2017-05-01)

Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure - The Current State of Sudden Cardiac Death Prophylaxis
by: Jayasree Pillarisetti, MD, et al.
Published: (2015-01-01)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
by: Gerrit Frommeyer, et al.
Published: (2016-03-01)

Comparative Effectiveness of Primary Prevention Implantable Cardioverter‐Defibrillators in Older Heart Failure Patients With Diabetes Mellitus
by: Abhinav Sharma, et al.
Published: (2020-06-01)

Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study
by: Johanna Mueller‐Leisse, et al.
Published: (2021-12-01)

Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator
by: Mariusz Klopotowski, et al.
Published: (2022-03-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Implantable cardioverter defibrillator therapy for secondary prevention in spontaneous coronary artery dissection: to place or not to place? This is the matter
by: Riccardo Scagliola, et al.
Published: (2020-03-01)

Patient Activity and Survival Following Implantable Cardioverter‐Defibrillator Implantation: The ALTITUDE Activity Study
by: Daniel B. Kramer, et al.
Published: (2015-05-01)

Arrhythmic Sudden Cardiac Death and the Role of Implantable Cardioverter-Defibrillator in Patients with Cardiac Amyloidosis—A Narrative Literature Review
by: Aleksandra Liżewska-Springer, et al.
Published: (2021-04-01)

Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator
by: Szymon Budrejko, et al.
Published: (2023-12-01)

Subcutaneous implantable cardioverter-defibrillator (SICD) for sudden cardiac death - A case series
by: Viveka Kumar, et al.
Published: (2022-04-01)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
by: Fernando Sérgio Oliva Souza, et al.

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
by: Anne‐Lotte C.J. van derLingen, et al.
Published: (2021-10-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
by: Jun Kishihara, MD, et al.
Published: (2016-02-01)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
by: Ryan T. Borne, et al.
Published: (2017-03-01)

Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy
by: Sarah A. Goldstein, et al.
Published: (2023-08-01)

Do Implantable Cardioverter-Defibrillators Prevent Sudden Cardiac Death in End-Stage Renal Disease Patients on Dialysis?
by: Beata Franczyk, et al.
Published: (2024-02-01)

Reassessment of practical usage and accumulation of real‐world data of wearable cardioverter defibrillator (WCD) in Japan—Design paper for J‐WCDR study
by: Shinichi Niwano, et al.
Published: (2021-02-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2015-10-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
by: Sarah Wolf, et al.
Published: (2023-04-01)

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter‐Defibrillators in the Cardiovascular Research Network
by: Robert T. Greenlee, et al.
Published: (2018-04-01)

Incidence of arrhythmic events in patients with implantable cardioverter-defibrillator for primary and secondary prevention of sudden cardiac death
by: Swiss Medical Weekly
Published: (2004-03-01)

The validity of current implantable cardioverter-defibrillator guidelines in a real-world population of adults with congenital heart disease: A single-center experience
by: Satoshi Kawada, MD, PhD, et al.
Published: (2022-06-01)

Implantable Cardioverter Defibrillators in Octogenarians: Clinical Outcomes From a Single Center
by: D.G. Wilson, MB ChB, et al.
Published: (2015-01-01)

Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry
by: Ibrahim El‐Battrawy, et al.
Published: (2023-09-01)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
by: Ido Goldenberg, et al.
Published: (2023-08-01)

Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study
by: Balbir Singh, et al.
Published: (2023-03-01)

Wearable Cardioverter-Defibrillator Used as a Telemonitoring System in a Real-Life Heart Failure Unit Setting
by: Christian Blockhaus, et al.
Published: (2021-11-01)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
by: Fabrizio Guarracini, et al.
Published: (2023-07-01)

Implantable cardioverter defibrillators in the prevention of sudden cardiac death
by: L A Bockeria, et al.
Published: (2017-12-01)